Life Science Investment Day Scandinavia. March 27, 2012.

Welcome and introduction

Jonas Ekstrand, SwedenBIO
Claes Hemberg, Avanza
Pia Kinhult, First Governor Region Skåne

Keynote Presentation: Bird&Bird

Hans Svensson, Partner and
Ludo M. Deklerck, Partner, Bird&Bird

International Investor Session - Who we are and what we want!

Investors and Business Partners

VINNOVA – Challenge driven innovation for future health

Jenni Nordborg, Head of Department, acting Director of Health, VINNOVA,
The Swedish Governmental Agency for Innovation Systems

EU FP 7 Funding Opportunities

Björn Kull, Senior Manager, EU Support Office, SwedenBIO

Turning molecules into products

Torkel Gren, Sales Director, Recipharm Pharmaceutical Development

Active Deal Flow Management – paving the ground for successful life science companies

Björn Larsson, Business Development & Investment Manager, GU Holding

How to attract an Investor

David Dible, Senior Director, Citigate Dewe Rogerson

Venture capital in the Malmö-Lund Region: current status and reflections on the Future

Ulf G Andersson, CEO, Det Medicinska Malmö

Intellectual Asset Management ; Get value from your patents - connect patents with business development

Tomas Lundquist, Awapatent

Turning IPR into cash: Successful licensing & distribution strategies for Japan
Tanja Dowe, Managing Partner, Innomedica Ltd.

Export and Financing into new geographical areas - Sweden in a unique position to expand

Gunnar Boström, Export Director, Phil Med Alliance

Emerging market opportunities: China

Grace Chen, Partner, Bird&Bird, Bejing, China

Licensing at MSD
Erik Lund, Director Scientific Liaison Scandinavia, Eastern EU and Turkey

AstraZeneca partnering strategies

Michael Vestling, Business Development Manager, CNS Pain

Boosting Medicon Valley into a World-Class Life Science Region

Anna Chérouvrier Hansson, Head of Life Science, Invest in Skåne
and Stig Jørgenssen, CEO, Medicon Valley Alliance

Medicon Village, MAX4 and ESS – new facilities for Life Science in Scandinavia and Europe

Allan Larsson, Former Minister of Finance, Chairman University of Lund, Board Director Mats Paulssons stiftelse

Incentives for the Scandinavian Life Science Industry – a comparative study

Erica Monfardini, PwC Luxemburg

UK’s new Life Science Strategy - opportunities for Scandinavian companies

Nigel Whittle, Technology Specialist, Life Sciences, UK Trade & Investment

Panel Discussion – Enabling Success for Scandinavian Life Science Companies

Concluding remarks
Erik Walldén, Chairman SwedenBIO Business & Finance working group